| milligrams | 10mg, 20mg, 5mg |
|---|
Tesamorelin
Research Grade Peptide
- Research Grade
- 99% Purity
- Third-Party Verified
Reference Strength: 5mg
Price range: R750,00 through R1599,00
CAS: 218949-48-5
Formula: C221H366N72O67S
Molecular Weight: 5136.75
Chemical Name / Amino Acid Sequence: tyr-ala-asp-ala-ile-phe-thr-asn-ser-tyr-arg-lys-val-leu-gly-gln-leu-ser-ala-arg-lys-leu-leu-gln-asp-ile-met-ser-arg (GHRH 1-44 analogue)
Tesamorelin
Price range: R750,00 through R1599,00
GHRH analogue — studied for visceral fat reduction and metabolic regulation in HIV-related research
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About Tesamorelin
Tesamorelin is a growth hormone-releasing hormone (GHRH) that stimulates your body to produce its own natural growth hormone, specifically targeting abdominal fat reduction.
How It Works in Research
Instead of injecting growth hormone directly, it signals your pituitary gland to release growth hormone naturally. This helps reduce visceral belly fat (the dangerous fat around organs) while preserving muscle mass and improving metabolic health.
Research Applications
Best for research into stubborn belly fat reduction, improving body composition in middle-aged subjects, and natural growth hormone optimization without external hormone replacement.
This is a simplified explanation for educational purposes. For detailed scientific information, see the Product Specifications section below.
Functional Performance Profile
Fat Metabolism
Body Composition
Hormonal Balance
Key Benefits
- Visceral Fat Reduction
- Growth Hormone Release
- Metabolic Support
Product Specifications
- Purity: 99.5%
- Form: Lyophilized peptide
- Storage: 2-9°C Refrigerated
Research Information
- Type: GHRH analog
- Focus: Visceral fat reduction
Scientific Information
Research Reference Parameters — Laboratory Use Only
- Initial phase: 1.0 mg once daily, 5 days on / 2 days off, administered by subcutaneous injection before bedtime
- Standard research range: 1.5 mg once daily, 5 days on / 2 days off, administered by subcutaneous injection before bedtime
- Advanced research range: 2.0 mg once daily, 5 days on / 2 days off, administered by subcutaneous injection before bedtime
- Research cycles typically extend 12-26 weeks
For laboratory research only.
Mechanism of Action
Tesamorelin binds to GHRH receptors in the anterior pituitary gland, stimulating natural growth hormone secretion. The released GH then promotes lipolysis specifically in visceral fat depots while maintaining anabolic effects in muscle tissue through IGF-1 mediation.
Key Research Characteristics
GHRH Analog Structure
Tesamorelin is a synthetic analog of growth hormone-releasing hormone with enhanced stability (44 amino acids with a trans-3-hexenoic acid group), providing sustained GH stimulation.
Visceral Fat Specificity
Unique research profile showing preferential reduction of visceral adipose tissue (VAT) while preserving subcutaneous fat, addressing metabolically harmful fat deposits.
Natural GH Pulse Preservation
Stimulates endogenous GH production without suppressing the hypothalamic-pituitary axis, maintaining natural pulsatile GH secretion patterns.
Potential Benefits in Research
Body Composition
- Significant visceral adipose tissue reduction (10-15% in studies)
- Preservation of lean muscle mass
- Improved waist circumference and body morphology
- Enhanced abdominal muscle definition
- Metabolic Health
- Improved lipid profiles (triglycerides, cholesterol)
- Enhanced insulin sensitivity in adipose tissue
- Reduced ectopic fat deposition in organs
- Improved metabolic syndrome markers
- Cognitive & Quality of Life
- Improved cognitive function scores in research
- Enhanced quality of life metrics
- Better sleep architecture
- Improved physical function scores
Safety Profile
Important: These side effects are reported from research studies and may vary by individual, dosage, and protocol. Always monitor subjects carefully and consult with qualified researchers.
Injection site reactions (redness, itching, pain)
- Joint pain or stiffness
- Muscle pain
- Peripheral edema (fluid retention)
- Carpal tunnel syndrome symptoms
- Potential glucose metabolism changes
- Rare: increased IGF-1 levels requiring monitoring
Research Applications
Visceral obesity and lipodystrophy research
HIV-associated adiposity redistribution syndrome
Metabolic syndrome and cardiovascular risk studies
Age-related body composition changes
Natural GH optimization protocols
Research Note: The information presented here is based on published scientific literature and research protocols. Individual results may vary based on research design, subject characteristics, and methodological approaches. Always conduct appropriate due diligence and follow institutional research guidelines.
REFERENCE RECONSTITUTION INFORMATION
RECOMMENDED RECONSTITUTION GUIDE This guide explains how research peptides are commonly reconstituted using bacteriostatic water (BAC water), and shows how dosing volumes correspond to syringe units. Always follow sterile preparation techniques when handling research peptides.
Always follow sterile preparation techniques when handling research peptides.
⚠️ DISCLAIMER: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
General Preparation
⚠️ Important: Allow product vial and BAC water to reach room temperature before reconstituting to reduce condensation uptake
- Use bacteriostatic water (BAC water) only
- Inject water slowly down the inside of the vial
- Do not shake the vial
- Gently swirl to dissolve the peptide powder
- Store refrigerated after mixing
- Use sterile technique when handling
Reference Handling Information
Reference information for laboratory handling of Tesamorelin.
- Route
- Subcutaneous injection
- Schedule
- Daily subcutaneous injections
- Injection Sites
- Rotate injection sites (abdomen preferred)
- Dosing
- Dose Range: 0.5 mg – 2.0 mg daily
- Use sterile technique when handling and administering
- Goal: Support fat loss and metabolic improvements via GH stimulation
- Cycle Length: 12–26 weeks continuous use
- Timing: Evening preferred
- Storage - Lyophilized: Refrigerate
- Storage - Reconstituted: Refrigerate
- Allow vial to reach room temperature before opening
Experimental Study Period
STUDY PERIOD
8–16 weeks
WASHOUT PERIOD
4–8 weeks
ADJUSTMENT NOTES
Not required
RESEARCH CONTEXT
Prevents receptor desensitisation and ensures cost-effectiveness
These tables show common research dosages. Always use an insulin syringe marked with units for accurate measurement. Contact our research support team for additional guidance.
View Certificate of Analysis
View Certificate of Analysis Each batch of Tesamorelin is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
DOWNLOAD COA99.5%
Verified Purity
3rd Party
Lab Tested
Certified
Quality Assured
Only logged in customers who have purchased this product may leave a review.
Related products
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
PURE PERFORMANCE LABS
Recommended Research Products
Explore related compounds commonly viewed alongside this product.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.
Reviews
There are no reviews yet.